![Emer Leahy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Emer Leahy
Director/Board Member at
INTENSITY THERAPEUTICS, INC.
Net worth: 23 833 $ as of 30/05/2026
Profile
Emer Leahy is President, Chief Executive Officer & Director at Psychogenics, Inc. since 2000.
Chief Executive Officer at Pgi Drug Discovery LLC since 2011.
Independent Director at Intensity Therapeutics, Inc. since 2016.
Independent Director at Pasithea Therapeutics Corp.
since 2021.
Former roles include Chairman-Trustees Board at BioNJ, Inc. from 2024 to 2026, Director at Biotechnology Innovation Organization, Director at NeuroNascent, Inc., Independent Director at Bright Minds Biosciences, Inc. from 2021 to 2022, Senior Vice President-Business Development at QHSLab, Inc., and Member-Business Review Board at Alzheimers Drug Discovery Foundation.
Education includes an MBA from The Trustees of Columbia University in The City of New York in 2000 and a doctorate from University College Dublin in 1990.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/04/2026 | 33,333 ( 0.1% ) | 23 833 $ | 30/05/2026 | |
| 14/04/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
Emer Leahy active positions
| Companies | Position | Start |
|---|---|---|
| INTENSITY THERAPEUTICS, INC. | Director/Board Member | 31/05/2016 |
| PASITHEA THERAPEUTICS CORP. | Director/Board Member | 31/05/2021 |
Psychogenics, Inc.
 Psychogenics, Inc. BiotechnologyHealth Technology Operates as a preclinical CRO that develops therapeutics for CNS and orphan disorders | Chief Executive Officer | 31/12/1999 |
Pgi Drug Discovery LLC | Chief Executive Officer | 31/12/2010 |
Former positions of Emer Leahy
| Companies | Position | End |
|---|---|---|
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Chairman | 11/02/2026 |
| BRIGHT MINDS BIOSCIENCES INC. | Director/Board Member | 24/04/2022 |
NeuroNascent, Inc.
 NeuroNascent, Inc. Pharmaceuticals: MajorHealth Technology Develops neurogenic small molecule therapeutics | Director/Board Member | - |
Alzheimers Drug Discovery Foundation
 Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology Operates as a research organisation | Corporate Officer/Principal | - |
| QHSLAB, INC. | Corporate Officer/Principal | - |
Training of Emer Leahy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
86
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
QHSLab, Inc.
 QHSLab, Inc. Financial ConglomeratesFinance Develops testing medical devices | Finance |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
NeuroNascent, Inc.
NeuroNascent, Inc. Pharmaceuticals: MajorHealth Technology Develops neurogenic small molecule therapeutics | Health Technology |
Intensity Therapeutics, Inc.
 Intensity Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops and markets proprietary intratumoral immunotherapy products for cancer treatment | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College Dublin
 University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alzheimers Drug Discovery Foundation
Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology Operates as a research organisation | Health Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
Psychogenics, Inc.
Psychogenics, Inc. BiotechnologyHealth Technology Operates as a preclinical CRO that develops therapeutics for CNS and orphan disorders | Health Technology |
Bright Minds Biosciences, Inc.
 Bright Minds Biosciences, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Pasithea Therapeutics Corp.
 Pasithea Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for mental health disorders | Health Technology |
Pgi Drug Discovery LLC |
- Stock Market
- Insiders
- Emer Leahy
